methylprednisolone aceponate has been researched along with Erythema in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nixon, R; Shen, S; Wong, GN | 1 |
| Heger-Mahn, D; Kecskés, A; Kuhlmann, RK; Lange, L | 1 |
| Jahn, P; Kecskés, A; Kleine-Kuhlmann, R; Lange, L; Wendt, H | 1 |
2 trial(s) available for methylprednisolone aceponate and Erythema
| Article | Year |
|---|---|
Comparison of the local and systemic side effects of methylprednisolone aceponate and mometasone furoate applied as ointments with equal antiinflammatory activity.
Topics: Administration, Topical; Adolescent; Adrenal Insufficiency; Adult; Anti-Inflammatory Agents; Double-Blind Method; Erythema; Female; Glucocorticoids; Humans; Male; Methylprednisolone; Middle Aged; Mometasone Furoate; Ointments; Pregnadienediols; Radiation Injuries; Telangiectasis; Ultraviolet Rays | 1993 |
Activity of topically applied methylprednisolone aceponate in relation to other topical glucocorticosteroids in healthy volunteers.
Topics: Administration, Topical; Adult; Anti-Inflammatory Agents; Dose-Response Relationship, Drug; Double-Blind Method; Erythema; Female; Glucocorticoids; Humans; Male; Methylprednisolone; Middle Aged; Skin; Ultraviolet Rays; Vasoconstrictor Agents | 1993 |
1 other study(ies) available for methylprednisolone aceponate and Erythema
| Article | Year |
|---|---|
Severe allergic contact dermatitis caused by topical bufexamac requiring hospitalization.
Topics: Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Betamethasone; Bufexamac; Chemotherapy, Adjuvant; Dermatitis, Allergic Contact; Edema; Erythema; Facial Dermatoses; Histamine Antagonists; Hospitalization; Humans; Methylprednisolone; Ointments | 2019 |